Press release
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Pipeline Review, H2 2017
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also plays an important role in trafficking of dendritic cells. The CC chemokines CCL3, CCL5, CCL17 and CCL22 signal through this receptor.
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 9 molecules are developed by Companies. The molecules developed by companies in Phase III, Preclinical and Discovery stages are 1, 6 and 2 respectively. Report covers products from therapy areas Oncology, Immunology, Central Nervous System and Dermatology which include indications Autoimmune Disorders, Solid Tumor, T-Cell Lymphomas, Allergies, Atopic Dermatitis, Breast Cancer, Cutaneous T-Cell Lymphoma, Epithelial Tumor, Gastric Cancer, Hematological Tumor, Kidney Cancer (Renal Cell Cancer), Mycosis Fungoides, Myelopathy, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Sezary Syndrome, T-Cell Leukemia and Tropical Spastic Paraparesis.
Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/1361359
The latest report C-C Chemokine Receptor Type 4-Pipeline Review, H2 2017, outlays comprehensive information on the C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
View Report @ https://www.marketresearchreports.biz/reports/1361359/c-c-chemokine-receptor-type-4-k5-5-or-cd194-or-ccr4-pipeline-review-h2-2017-market-research-reports
Scope
- The report provides a snapshot of the global therapeutic landscape for C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)
- The report reviews C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics and enlists all their major and minor projects
- The report assesses C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Overview
C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also plays an important role in trafficking of dendritic cells. The CC chemokines CCL3, CCL5, CCL17 and CCL22 signal through this receptor.C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Therapeutics Development
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Companies Involved in Therapeutics Development
Affitech A/S
AstraZeneca Plc
ChemoCentryx Inc
Corion Biotech Srl
FLX Bio Inc
Globavir Biosciences Inc
Kyowa Hakko Kirin Co Ltd
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4)-Pipeline Review, H2 2017 here
News-ID: 800952 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for CCR4
Cutaneous T-Cell Lymphoma Market to Reach USD 2.35 Billion by 2034
Cutaneous T-cell lymphoma (CTCL) is a rare and chronic form of non-Hodgkin lymphoma that primarily affects the skin. The two most common subtypes, mycosis fungoides and Sézary syndrome, are characterized by slow progression but can significantly impact quality of life. The disease often requires long-term management, with treatment strategies evolving from skin-directed therapies to systemic immunotherapies and targeted agents.
Over the next decade, the CTCL market is expected to benefit from…
Mycosis Fungoides Treatment Market 2025 | Immunotherapy, Phototherapy & Targeted …
The Mycosis Fungoides Treatment Market is experiencing steady growth and is driven by rising incidence rates linked to immune system dysfunction, increased utilization of effective therapeutics, widespread adoption of phototherapy, radiation therapy, and supportive care measures. Emerging opportunities in the market include advancements in chemotherapy, a rising demand for monoclonal antibodies as first-line treatments, the development of novel topical therapies, and increasing investment in research and development of targeted and…
Emerging Trends Influencing The Growth Of The Poteligeo Market: Securing Regulat …
The Poteligeo Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Poteligeo Market Size and Projected Growth Rate?
The market size for Poteligeo has seen an XX (HCAGR) rise in recent years. Growth is predicted to increase from $XX million in 2024 to $XX…
Top Factor Driving Poteligeo Market Growth in 2025: Rising Prevalence Of Lymphom …
"What Is the Future Outlook for the Poteligeo Market's Size and Growth Rate?
In the past few years, the Poteligeo market size has seen an increase of $XX. It is predicted to expand from a value of $XX million in 2024 to an escalated value of $XX million in 2025, experiencing a Compound Annual Growth Rate (CAGR) of $XX%. Factors such as government health schemes, increased spending on healthcare, growing instances…
C-C Chemokine Receptor Type 4 Market Size, Outlook 2031 by Key Companies- Affite …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global C-C Chemokine Receptor Type 4 Market size was valued at USD 416.2Million in 2023 and is projected to reach USD1,200 Million by 2031, growing at a CAGR of 17.2% during the forecasted period 2024 to 2031.
What is the current outlook for the C-C Chemokine Receptor Type 4 (CCR4) Market?
The C-C Chemokine Receptor Type 4 (CCR4) market is poised for…
Fc Protein and Glycoengineered Antibodies Market Development is Changing Busines …
Monoclonal antibodies are developed by identical immune cells, which have a therapeutic use. The crystallized fragments (Fc) protein and glycoengineered antibodies are known as the next generation antibodies. These monoclonal antibodies are immunoglobulin G (IgG) type of molecules, which are attached to a glycan residue on crystallisable fragment. Glycoengineering is the method by which these antibodies are created. They have varied applications for the treatment of diseases such as multiple…
